S
Sol-Gel Technologies Ltd D
D
SLGL
43.970
USD
2.42
(5.82%)
Post Trading
حجم التداول
17
الربح لكل سهم
-1
العائد الربحي
-
P/E
-36
حجم السوق
122,491,054
العنوان: Sol/Gel Technologies Ltd
القطاع: Healthcare
الصناعة: Biotechnology
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includesSGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease andother rare keratosis-related indications such as PC, PPK and Olmsted.